Net sales climbed to $719.3 million from $711 million in Q4 of fiscal 2018, beating the $660.4 million analysts' consensus. The company attributed the period's sales growth to improved results from the aerospace and defense, cellular and computing end markets that offset the softness from other commercial end markets.
Assuming its Chinese factories can resume operations on Feb. 10, TTM estimated $580 million to $620 million in revenue for fiscal Q1 and $0.05 to $0.11 in non-GAAP EPS, including a negative impact of about $0.09 per share related to the additional nine days of facility closure due to the coronavirus outbreak. The company warned that an extended shutdown will further impact its fiscal Q1 results.
Analysts are currently expecting Q1 adjusted EPS of $0.18 on revenue of $603.9 million.
Price: 15.08, Change: +0.09, Percent Change: +0.60
|2020 and 2021 Earnings Estimates for Syneos Health L...|
|Sysco's Consensus Projections for Q3, 2020, and 2021...|
|2020, 2021, and Q1 Earnings Estimates for Stryker Co...|
|2020, 2021, and Q1 Earnings Estimates for Synchrony ...|
|Insider Trends: 90-Days of Insider Buying at Towers ...|